Back to Journals

Open Access Journal of Clinical Trials

ISSN: 1179-1519

Professor Arthur E. Frankel

Professor Frankel

Chief of Hematology & Oncology, Department of Medicine, West Palm Beach VA Medical Center, West Palm Beach, FL, USA

Arthur E. Frankel, MD was born in Austin, Texas, attended Harvard College and Harvard Medical School and completed medical training at Yale University, the National Institutes of Health and Stanford University. He practiced and taught at Duke University, the Medical University of South Carolina, Wake Forest University, Texas A&M, the University of Texas Southwestern, and the University of South Alabama. He is now Chief Hematology and Oncology at the West Palm Beach VA Medical Center.

His clinical focus is malignant hematology, cutaneous malignancies and GU cancers. He has done research including the discovery of the first mammalian oncogenes, the generation of the first Her2 and PSA monoclonal antibodies, the finding of one of the first second site revertant enzyme mutations, discovery of a third lectin binding site on the plant toxin ricin, production of anti-leukemia fusion proteins, and reporting the first gut microbes critical for melanoma immunotherapy response. His interleukin 3-directed fusion protein was approved by the FDA in 2018 for a rare type of leukemia. His current goal is to provide outstanding and cutting edge clinical care to veterans.

Editorial Board

Abdelhamid Attia, Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cairo, Cairo, Egypt

Adam M. Brufsky, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, USA

Rudolph J. Castellani, Professor of Pathology, Director, Center for Neuropathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA

Mario Cazzola, Honorary Professor of Respiratory Medicine, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy

William Checkley, Associate Professor of Medicine, International Health, and Biostatistics; Director, Fogarty Global Health Fellowship at Johns Hopkins University; Director, Center for Global Non-Communicable Diseases, Division of Pulmonary and Critical Care Johns Hopkins University, Baltimore, Maryland, USA

E. David Crawford, Professor of Urology, University of San Diego, Koman Family Outpatient Pavilion, Denver, CO, USA

Tarek El-Bialy, PhD, FRCD(C), EMBA, ABO Alexander von Humboldt Experienced Research Fellow, Senator, University of Alberta Senate RCDC, Councilor for Orthodontics, Professor of Orthodontics and Biomedical Engineering, Faculty of Medicine and Dentistry, 7-020D Katz Group Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada

Stephen E. Gitelman, MD, Mary B. Olney, MD / KAK Distinguished Professorship in Pediatric Diabetes and Clinical Research; Professor of Pediatrics; Chief, Division of Pediatric Endocrinology and Diabetes, University of California at San Francisco, San Francisco, CA, USA

Robert A. Hauser MD, MBA, Professor of Neurology, Director, USF Parkinson’s Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, FL, USA

Mallory O. Johnson, Department of Medicine, University of California, San Francisco, CA, USA

Roger S. McIntyre, M.D., FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto; Head, Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

Ian S. Zagon, Professor, Department of Neural and Behavioural Sciences, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, PA, USA